| East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More | Ben Fidler | 09/04/15 | Boston |
| Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug | Ben Fidler | 08/31/15 | Boston |
| Promedior Sees Hope in Small Myelofibrosis Study | Ben Fidler | 05/30/14 | Boston |
| Promedior Joins Ranks of Woman-Helmed Biotechs in Massachusetts | Catherine Arnst | 12/19/12 | Boston |
| Promedior, Aveo, Ra, and More Boston Life Sciences Headlines | Erin Kutz | 05/18/12 | Boston |
| Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO | Arlene Weintraub | 05/15/12 | Boston |
